Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.19 USD | +2.20% | +1.45% | -23.82% |
May. 15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.82% | 36.55M | |
+34.74% | 50.85B | |
+0.61% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.85% | 26.11B | |
-21.57% | 19.13B | |
+8.73% | 13.05B | |
+26.98% | 12.16B | |
+24.38% | 12.08B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Insider Trends: Marker Therapeutics Insider 90-Day Buying Trend Added to with Purchase